Assessing Insomnia in Active-Duty Service Members in a Military Primary Care Clinic.

Journal Article (Journal Article)

Background

Insomnia is a significant problem in the U.S. military, affecting the health, resiliency, and readiness of service members (Seelig et al., 2016). Although insomnia is a common sleep disorder among active-duty personnel (Mysliwiec et al., 2013), it often goes unrecognized and untreated because sleep disturbances are not routinely assessed during military primary care visits (U.S. Navy Medicine, 2014).

Objective

To introduce an evidence-based assessment for insomnia-the Insomnia Severity Index (ISI)-into a military primary care setting to increase the number of service members assessed for insomnia.

Methods

The ISI was integrated into the patient intake process at a military primary care clinic serving active-duty service members exclusively. Data were collected from 180 patients before implementation and 164 patients after implementation to compare the number of sleep assessments conducted. An independent samples t -test and Fisher's exact test were used to examine whether the ISI intervention led to an increase in insomnia assessment.

Results

A significant increase was found in patients who were evaluated for insomnia from pre-implementation (13.9%, n = 25/180) to post-implementation (90.3%, n = 148/164), p < .0001.

Conclusions

A sleep screening process can be effectively implemented at a military primary care facility to increase the number of active-duty service members assessed for insomnia.

Implications for nursing

Sleep assessment is critically needed to identify service members with sleep disorders that may negatively impact their physical and mental health. An evidence-based screening tool is an important preventive measure that can be integrated into primary care visits to ensure routine evaluation of sleep.

Full Text

Duke Authors

Cited Authors

  • Cobbs, L; Champagne, M; Turner, B; Perry, M

Published Date

  • October 2019

Published In

Volume / Issue

  • 12 / 2

Start / End Page

  • 202 - 211

PubMed ID

  • 32745032

Pubmed Central ID

  • 32745032

Electronic International Standard Serial Number (EISSN)

  • 2380-9426

International Standard Serial Number (ISSN)

  • 2380-9418

Digital Object Identifier (DOI)

  • 10.1891/2380-9418.12.2.202

Language

  • eng